Focused Ultrasound-Induced Blood-Brain Barrier Opening Enhanced α-Synuclein Expression in Mice for Modeling Parkinson's Disease.

Pharmaceutics · 2022 · PMC8876143 · PMID 35214176

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Our neurochemical analysis revealed a highly significant decrease in DA (≥70%) in MPTP-treated mice, while the greatest decline in DA (≥85%) took place in the IV-60 μg LpαSNCA group with UTMD-treated mice.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.